Bioinformatics Analysis of microRNAs Associated with Metastatic Potential in Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• MicroRNA (miRNA) dysregulation is implicated in breast cancer (BC) initiation, progression, and metastasis.
• Specific miRNAs modulate tumor behavior and drug responses in BC.

Purpose of the Study:

• To identify and characterize candidate miRNAs involved in epithelial-mesenchymal transition, migration, invasion, and hormonal regulation in BC using bioinformatics.
• To evaluate the clinical significance and functional relevance of identified miRNAs in breast cancer.

Main Methods:

• Systematic integration of miRNA profiling data from BC cell lines and patient samples (primary tumors and lymph node metastases).
• Bioinformatic analysis including target prediction, miRNA-mRNA network construction, and functional enrichment analysis.
• Quantitative real-time PCR (qPCR) for miRNA expression in BC cell lines.

Main Results:

• Five key differentially expressed miRNAs (DE-miRNAs) were identified: miR-146a-5p, miR-222-3p, miR-205-5p, miR-141-3p, and miR-200c-3p.
• Upregulated miR-222-3p demonstrated pro-metastatic characteristics and clinical relevance.
• Downregulation of miR-200 family members and miR-205-5p correlated with negative clinical features and aggressive cancer-related genes.

Conclusions:

• The identified DE-miRNAs, particularly miR-222-3p, miR-200 family, and miR-205-5p, play significant roles in breast cancer progression, metastasis, and clinical outcomes.
• These findings support the functional relevance of these miRNAs as potential biomarkers or therapeutic targets in breast cancer.